The Chinese government has announced plans to consolidate their
outsourcing industry in an effort to capture business from other
developing countries such as India.
A number of executives and technical staff at small to medium size
pharmaceutical firms are unaware of how to use their resources
effectively to comply with new EMEA guidelines, designed to
minimise the environmental impact of compounds,...
Analytical laboratory LGC has set up an initiative to develop a new
approach to training for analysts working in molecular
laboratories, with a novel e-learning tool.
The UK's Department of Trade and Industry (DTI) has pledged its
support to an ultrasound spectroscopy project conducted by LGC, to
evaluate its potential as a Process Analytical Tool (PAT) for
non-destructive testing, real time...
German biotech company MediGene and Sanofi Pasteur have signed a
deal to develop new monoclonal T cell receptors that the vaccine
maker will use to develop and validate vaccines more efficiently.
NNE and Fresenius ProServe yesterday announced they had reached an
agreement by which NNE will acquire Fresenius' subsidiary,
engineering company Pharmaplan GmbH.
Crucell yesterday announced it had received the first orders from
US-headquartered Wyeth Biotech. The order represents the first move
following the finalisation of the contract manufacturing agreement
between the two companies at...
Pharma company Medichem has announced it has passed a US Food and
Drug Administration (FDA) inspection without any problem for the
third consecutive time.
A UK based firm aims to take up the fight against drug
counterfeiters with its innovative imaging and spectroscopy
products. TeraView says its technology could aid regulators and law
enforcement agencies screen for potentially lethal...
Dr Reddy's Laboratories has boosted its ability to serve Western
pharmaceutical markets with an increase in its manufacturing
capacity for drug formulations.
Biologic drug manufacturing is slowly starting to take off in
Singapore and is expected to be a key component of the country's
drug manufacturing activity in the future.
The first radio frequency identification (RFID) tag that can resist
gamma irradiation has been developed to track pharmaceutical
products early on and throughout the supply chain.
Almost 130 jobs will be lost at BASF's Minden site as the company
succumbs to growing pressure from the Asian generic active
pharmaceutical ingredient (API) market.
Fine chemicals maker Siegfried Holdings has agreed to sign over
part of the production capacity of its Zofingen production plant to
US biotech Celgene Corp in a collaboration worth €34.9m.
Baxter is expanding its lyophilisation capacity at its German
facility to support future growth of its contract manufacturing
business for anti-cancer drugs.
Indian pharma firm Panacea Biotec has taken a 10 percent stake in
UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m
(€1.4m) under a new joint venture deal signed between the two
companies.
The UK subsidiary of ProMetic Life Sciences has signed a deal with
Novartis to develop a new purification technology for recombinant
protein vaccines that is claimed to be more efficient and cheaper
than currently used methods.
New flow reactor heater allows high-speed, multi-step reactions in
front of your eyes allowing users to monitor progress and intervene
in case problems to avoid time and reagent waste.
Swiss custom manufacturer Lonza and Singapore's BioOne Capital have
announced a new joint venture to build a $350m (€263m) large-scale
manufacturing facility in Singapore.
Millipore has introduced a new container film - PureFlex - that
ties in with the trend towards increasing use of disposable
products within the bioprocessing sector.
AAIPharma has announced it has signed a contract manufacturing
agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims
to provide a "one-stop drug development solution" for drug makers.
Cardinal Health, the leading contract manufacturer for the
pharmaceutical industry, has announced its plans to sell its drug
manufacturing and packaging unit in order to focus on its
health-care business.
Biotech company Progen has decided to manufacture its new
anti-cancer drug in-house rather than outsource it in order to save
on costs after the FDA gave the thumbs up for the manufacture of
the drug for its upcoming phase III clinical...
ReSearch Pharmaceutical Services (RPS), a US based outsourcing
company, has announced expansion plans in Latin America. This
reflects the increasing trend of pharmaceutical companies
exploiting the cost benefits associated with outsourcing...
The necessity for drug manufacturers to comply with increasingly
rigorous regulations is driving laboratory information management
systems (LIMS) growth, according a new study.
Dutch biotech company Crucell said last week that it had completed
its acquisition of SBL Vaccin in an agreement worth €39.4m, but
remained tight-lipped about its plans for the Swedish firm's
contract manufacturing business.
A new X-ray microscopy technique will enable scientists to view
materials less than a nanometre in size. The development will help
scientists visualise reactions at surfaces, such as corrosion and
catalytic reactions, in real-time.
The growing inhaler device market is driving demand for automated
quality control (QC) testing equipment for these products,
according to Astech Projects.
Singapore has successfully completed the first phase of its
biomedical science (BMS) initiative and is now pushing the second
phase forward in order to drive growth in its pharma industry
further.
Drug giant GlaxoSmithKline (GSK) has been awarded a contract with
the US government to supply 800,000 doses of flu vaccine to the US,
where a bird flu pandemic still remains a threat.
Integra Biosciences is hailing its novel cell culture system as
being responsible for dramatically transforming the effectiveness
of small-scale antibody production.
General Electric (GE) has launched a range of
ultra-high-performance plastics that it claims will answer the need
for cost-effective injection moldable resin.
India's Aurobindo Pharma has decided to cut loose its bleeding
Chinese pharma subsidiary - while still holding on to its
ingredients making operation - and instead focus on a new
investment in India.
International drug firms are increasingly turning to Taiwan for the
low-cost made-to-order processing of active pharmaceutical
ingredients (APIs), according to the Taiwan External Trade
Development Council (TAITRA).